GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 3914-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 39GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 39GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Add relating to AGM & EvotingGLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 39GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Reg. 34 (1) Annual Report.
With reference to Annual Report submitted by us on 4th June 2024, we would like to inform you that there is typo error in page 8 (in legends of the graph) in the Annual report which is been rectified and uploaded on the exchanges.GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - 99Th Annual General Meeting Notice
99th Annual General Meeting to be held on 28th June 2024GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Business Responsibility and Sustainability Reporting (BRSR)
BRSR Report for Financial year 2023-24GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Reg. 34 (1) Annual Report.
Annual Report for Financial year 2023-24GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Clause 30
Disclosure under clause 30GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 39